Navigation Links
Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. Hospitals Using McKesson Paragon or Horizon According to HIMSS Analytics
Date:9/19/2013

Lexington, MA (PRWEB) September 19, 2013

Imprivata®, a leading global provider of healthcare IT security solutions, today announced that Imprivata OneSign® is the most widely selected single sign-on (SSO) solution amongst U.S. hospitals using a McKesson Paragon or Horizon electronic health records (EHR) system with a 46 percent market share, according to the most recent data from HIMSS Analytics. Imprivata will showcase its SSO and authentication management solutions as well as Imprivata Cortext®, its HIPAA-compliant secure text messaging application, in booth #600 at McKesson InSight Users Group 2013 Annual Conference (September 24-27, 2013 in Orlando, Fla.).

In addition, two Imprivata customers will lead speaking sessions at McKesson InSight about Imprivata’s solutions for delivering fast, secure No Click Access® to McKesson Paragon, Horizon and other clinical applications to enable better focus on patient care:

  •     Joe Jagodzinski, systems security at Promedica (Toledo, Ohio), will deliver a presentation titled “When Once is Not Enough: How Two-factor Authentication at the Point of e-Prescribing Reduced Risk and Increased Productivity” (session #3168) on Friday, September 27 at 8:30 a.m. EDT in room W108A. In this session, Jagodzinski will explain how ProMedica strikes a balance between security and productivity by incorporating SSO and two-factor authenti
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
2. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. MEDITECH Customers According to HIMSS Analytics
3. Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review
4. Imprivata Cortext Secure Text Messaging Solution Validated as HIPAA Compliant by ecfirst
5. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. Hospitals Using Siemens Soarian Clinicals according to HIMSS Analytics
6. Cholesterol Levels Vary Widely by Country: Study
7. Heart Attack Survival Varies Widely Among Hospitals, Study Finds
8. Injury-Linked Deaths Vary Widely Among States
9. Brain-Injury Recovery Varies Widely Among Children
10. Drug Widely Used to Treat MS May Not Slow Progression
11. Cancer Rates Vary Widely by State, Race: CDC Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... LINCOLN, R.I. (PRWEB) September 16, 2014 ... from Sunday, Sept. 14, through Saturday, Sept. 20, ... make sure children are safe and secure while in ... from the National Traffic Highway Safety Administration (NHTSA), ... did not read the instruction manual when installing child ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Regulatory ... available regulatory information, has become a crucial skill ... device and biotechnology sectors. Regulatory Intelligence 101 ... Society (RAPS) serves as an essential guide ... Regulatory Intelligence 101 examines available regulatory intelligence tools, ...
(Date:9/16/2014)... (HealthDay News) -- Illegal drug use among teens in the ... federal report. Encouragingly, the new study also found ... products among young people between the ages of 12 and ... survey of 70,000 people aged 12 and older across the ... or abuse problems among this age group also dropped from ...
(Date:9/16/2014)... San Francisco, September 15, 2014Patients with inoperable, early-stage ... (SBRT) have a five-year survival rate of 40 ... American Society for Radiation Oncology,s (ASTRO,s) 56th Annual ... considering that historically conventional RT resulted in poor ... This study is an update of RTOG 0236, ...
(Date:9/16/2014)... of researchers at Boston University and Stanford University School ... the motion patterns of bacteria in real time and ... a bacterial colony. , The researchers chemically attached colonies ... a microscopic beam anchored at one end, similar ... to that of the bacteria. As the cantilever itself ...
Breaking Medicine News(10 mins):Health News:Amica Offers Tips During Child Passenger Safety Week 2Health News:RAPS Publishes Regulatory Intelligence 101 Book 2Health News:Fewer U.S. Teens Using Illegal Drugs and Alcohol, Report Finds 2Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 2Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 3Health News:And so they beat on, flagella against the cantilever 2
... kinesin CENP-E (GSK923295A) demonstrates a novel mechanism of inhibiting ... panel of human tumor cell lines in vitro: Abstract ... designed to inhibit a single protein that functions only ... range of cancer cell lines, say researchers from GlaxoSmithKline. ...
... Pharmaceuticals, a New,Jersey-based developer, manufacturer and distributor ... API and finished,dosages development and manufacturing company ... to develop, manufacture, market and distribute,several products ... product pipeline,will include at least ten ophthalmic ...
... Members of Congress Call Today for a "Medicare-Operated" ... adults and persons,with disabilities should have the option ... program to eliminate the consumer,exploitation that plagues the ... insurance companies, concludes Consumers Union and the Medicare,Rights ...
... Standards Panel (HITSP) has identified a set of,standards ... medical,information secure in an electronic environment. The standards ... only be used by authorized,personnel for official purposes., ... and privacy architecture is,the latest in a series ...
... medical care, researchers suggest , , TUESDAY, Oct. 23 (HealthDay News) ... remained constant since 2000, with some one-third of all Americans ... , But less than 25 percent of those at high ... sex or are intravenous drug users -- have been tested ...
... Affordable Treatments for the World,s ... episode of the Charlie Rose Science Series will ... -- ranging from the AIDS crisis to malaria, ... neglected diseases. A group of experts ...
Cached Medicine News:Health News:Experimental cancer pharmaceuticals under trial 2Health News:Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals 2Health News:Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals 3Health News:Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit 2Health News:Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit 3Health News:HITSP Defines Overarching Set of Healthcare Security and Privacy Standards 2Health News:Many at Risk for HIV Not Being Tested 2Health News:Many at Risk for HIV Not Being Tested 3Health News:Charlie Rose Science Series Episode #10 - GLOBAL HEALTH October 29, 2007 2
(Date:9/16/2014)... 2014  DNAtrix, Inc., experts in oncolytic virus ... treated with the company,s lead product, DNX-2401, a ... randomized, multicenter, open-label Phase Ib study for patients ... with leading neurosurgeons and neuro-oncologists in the US, ... randomized Phase Ib study of DNX-2401 at Moffitt ...
(Date:9/16/2014)... 16, 2014 Henry Schein, Inc. (NASDAQ: ... of health care products and services to office-based ... that Stanley M. Bergman, Henry Schein,s Chairman of the Board ... healthcare services panel at the Leerink Partners Services ... be Dr. Stohler, Dean of Columbia University,s College ...
(Date:9/16/2014)... BOSTON , September 16, 2014 ... Fiona Marshall , will give a presentation entitled " ... StaR ®   technology " ... and Development " virtual symposium run by Chemical & Engineering ... symposium is on Wednesday, 24 September 2014; Dr Marshall,s presentation ...
Breaking Medicine Technology:DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 2Henry Schein To Present At The Leerink Partners Services Roundtable 2Heptares to Present on Structure-Based Drug Design Using G Protein-Coupled Receptors at Inaugural Chemistry & Engineering News Virtual Symposium 2
... N.J., May 24, 2012 Watson Pharmaceuticals, Inc. ... its subsidiary, Watson Laboratories, Inc., filed an Abbreviated ... and Drug Administration (FDA) seeking approval to market ... is a generic version of Auxilium Pharmaceuticals, Inc.,s ...
... ANTONIO, May 24, 2012 /PRNewswire-iReach/ -- An ... Life Science Venture Forum in Houston, Texas named TransCU ... of ten Most Promising Life Science Technologies .  ... and innovations to hundreds of early-stage investors, venture capitalists, ...
Cached Medicine Technology:Watson Confirms Testim® Patent Challenge 2Watson Confirms Testim® Patent Challenge 3New Chronic Wound Therapy Awarded at Texas' Largest Life Science Event 2
... KIMBERLY-CLARK CLOtest Rapid Urease Test is ... Standard among urease tests because of its ... by Barry Marshall, MD. who, along with ... discover the correlation between H. pylori and ...
... Rapid Test Strip and Device are rapid ... antibodies to Helicobacter pylori (H. pylori) in ... in the diagnosis of H. pylori infection ... older. They are intended for health professionals ...
... pylori WB test is a ... detection of lgG antibodies specific ... whole blood. This test kit ... in the diagnosis of H.pylori ...
... based on a lateral flow chromatography ... the qualitative detection of Helicobacter pylori ... Platinum HpSA, a microtiter assay from ... accepted as an accurate tool for ...
Medicine Products: